Rakesh Jhunjhunwala, a famous Indian investor, passed away on August 14, local time, at the age of 62.

In the Forbes rich list, his latest net worth is fixed at 5.8 billion US dollars (about 39 billion yuan).

　　Jin Junwala is an investor with the ability to turn a stone into gold, known as India's Warren Buffett.

The first Indian to become a billionaire through the stock market, he is optimistic about the prospects of India's economy and companies, and has gained a loyal retail following.

　　Indian Prime Minister Narendra Modi commented on Kim Junwala on Twitter: He is indomitable, dynamic, witty and insightful, leaving an indelible contribution to the financial world.

He is also enthusiastic about progress in India.

His passing is sad.

　　It is reported that Jin Junwala began to get involved in the stock market while in college.

His father was a tax officer.

His interest in stocks stemmed from his father discussing the market with friends.

Although his father guided him in the market, he never gave him money to invest.

With the character of an adventurer, Jinjun Vala can only secretly ask his cousin to borrow 5,000 rupees (about 425 yuan) to enter the stock market as the principal.

The investment that changed his fortune came in 1986, when he bought 5,000 shares of Tata Tea at Rs 43 per share, which rose to 143 per share within 3 months. The rupee more than tripled at once, and after 3 years, he earned 2.5 million rupees.

　　He has since become a partner at Rare Enterprises, an asset management firm, managing his own portfolio.

　　As of June this year, Jinjunwala has publicly held 19 stocks. In addition to his life's proud works Titan, CRISIL, and Star Health occupy an important share of the investment portfolio, the remaining positions also include Indian brand footwear chain Metro Brands, Indian hotels Ltd, Tata Communications, Commonwealth Bank, Va Tech Wabag focusing on municipal and industrial water treatment, pharmaceutical CMO/CDMO suppliers Jubilant and Dishman Carbogen Amcis and Bilcare in pharmaceutical packaging manufacturing, crop care company Rallis, vocational training provider Aptech , Indian edible oil and branded food maker Agro Tech Foods, Indian real estate developer NCC Limited, DB Realty, Prozone Intu Properties, and auto parts maker Autoline Industries.

　　Jinjunwala is good at investing in big consumer stocks, including pharmaceuticals, consumption, insurance, etc. He often said: "It's not what you buy that matters, but the price you buy." This investment philosophy helps him buy Titan Judging when dealing with troubled stocks like Lupin, he used to say about value investing: "If the girl is pretty, suitors will come."

　　During his 37-year career, he has invested in many stocks, but there are five stocks that have contributed greatly to the growth of his wealth.

They are Titan, Sesa Goa, Lupin, CRISIL and Star Health.

Titan

　　It mainly produces fashion accessories such as jewelry, watches and glasses.

　　Titan is said to be Jinjunwala's favorite stock.

In 2002-2003, when he first bought Titan from a prominent New York-based fund manager, the company performed poorly, with debt several times its market value.

　　He started buying the stock in 2002-2003, when the share price was hovering around Rs 3-4.

He kept building up his stake in the watch and jewelry maker, and even during the 2008 global recession he only sold about 600,000 of his 4.4 million shares.

Later in 2012, he raised his stake to 10.28%.

Currently, the Rakesh Jinjunwala family holds a 5.05% stake worth Rs 11,081 crore.

Lupin

　　is an Indian multinational pharmaceutical company and one of the largest generic drug companies in the world by revenue.

The company's focus areas include pediatrics, cardiovascular, anti-infectives, diabetes, asthma and anti-tuberculosis.

　　He started buying Lupin shares in 2003, when Lupin had a market capitalization of around Rs 500 crore.

In June 2008, he held a 4.29% stake in Lupin worth Rs 154 crore.

In September last year, when the market value of the company was about 440 billion rupees, Jinjunwala gradually reduced his stake and exited the company entirely.

Sesa Goa

　　A company of the Vedanta Group engaged in the exploration, mining and processing of iron ore.

　　Sesa Goa was one of Jinjunwala's early big bets, which boosted his fortune.

Kim Junwala bought 400,000 shares of Sesa Goa in 1989, when the iron ore industry was struggling, and the shares were trading at Rs 25.

He sold the shares in three tranches - the first tranche of 250,000 shares at Rs 65, the second tranche of Rs 175 and the last tranche of Rs 2,200.

CRISIL

　　CRISIL is an analyst firm in India that provides ratings, research, risk and policy advisory services, and is a subsidiary of US firm S&P Global.

CRISIL is India's first credit rating agency.

　　Jinjunvala started buying CRISIL shares in 2003.

After initially buying 10,000 shares, he later added 5.5 million shares in September 2006.

Shares are bought at Rs 400 to Rs 500.

In 2013, Rakesh Jinjunwala sold 400,000 shares for over Rs 460 crore.

Currently, he owns a 5.48% stake in the rating agency worth Rs 13.2 crore.

Star Health

　　An Indian multinational health insurance company that provides services in health, personal accident and overseas travel insurance both directly and through various channels including agents, brokers and online.

　　Jinjunwala's investment in Star Health made a big profit.

Rakesh and Rekha hold a combined 17.26% stake worth Rs 69.8 crore, and between March 2019 and November 2021, Jinjunwala made nine transactions at an average price of Rs 155.28 per share ahead of the company's IPO, Having bought shares in the insurance company, his total investment in the company is around Rs 1,287 crore.

The November 2021 launch price is around Rs 900.

Despite the poor first-day trading performance, Jinjunwala still made huge returns.